Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genistein for Chemotherapy Toxicity in Pediatric Cancer
NCT02624388Phase 2Terminated
- Sponsor
- University of Virginia
- Start
- Aug 2016
- Primary completion
- Sep 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of genistein in chemotherapy-induced neutropenia (CIN), chemotherapy-induced toxicity, sponsored by University of Virginia. Started Aug 2016; status: terminated.
02
Drugs
genistein
03
Conditions
chemotherapy-induced neutropenia (CIN)chemotherapy-induced toxicity
Beyond the preview
Go deeper on NCT02624388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624388.